Articles by tag: regeneron

Gene therapy for OTOF deafness: hearing restoration

FDA approved the first gene therapy for hereditary deafness Otarmeni. Learn how a single injection restores hearing in OTOF mutation and changes the market.

FDA approved the first gene therapy for hereditary deafness

Regeneron's Otarmeni restores hearing to normal in 42% of patients. The therapy treats OTOF gene mutations with a single injection. Learn how AAV vector technology has for the first time restored the ability to hear a whisper.